These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 12527440)

  • 61. Farmers act to avert foot-and-mouth crisis.
    Giles J
    Nature; 2001 Mar; 410(6824):4. PubMed ID: 11242000
    [No Abstract]   [Full Text] [Related]  

  • 62. Foot-and-mouth epidemic: the choices.
    Sharp D
    Lancet; 2001 Mar; 357(9258):738. PubMed ID: 11253964
    [No Abstract]   [Full Text] [Related]  

  • 63. Early response of cattle and swine to inactivated foot-and-mouth disease vaccine.
    Graves JH; McKercher PD; Farris HE; Cowan KM
    Res Vet Sci; 1968 Jan; 9(1):35-40. PubMed ID: 5689040
    [No Abstract]   [Full Text] [Related]  

  • 64. Modelling the spread of foot-and-mouth disease in Australia.
    Garner MG; Beckett SD
    Aust Vet J; 2005 Dec; 83(12):758-66. PubMed ID: 16395942
    [TBL] [Abstract][Full Text] [Related]  

  • 65. On-farm eradication of foot-and-mouth disease as an alternative to mass culling.
    Poulin MC; Christianson WT
    Vet Rec; 2006 Apr; 158(14):467-72. PubMed ID: 16603550
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Progress in the development of DNA vaccines against foot-and-mouth disease.
    Fowler VL; Barnett PV
    Expert Rev Vaccines; 2012 Apr; 11(4):481-93. PubMed ID: 22551033
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical variation in foot and mouth disease: cattle.
    Kitching RP
    Rev Sci Tech; 2002 Dec; 21(3):499-504. PubMed ID: 12523690
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
    Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W
    Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Outbreaks and diagnosis of foot-and-mouth disease serotype O in the Republic of Korea, April-June 2010.
    Park JH; Lee KN; Ko YJ; Kim SM; Lee HS; Park JY; Yeh JY; Kim MJ; Lee YH; Sohn HJ; Moon JS; Cho IS; Kim B
    Transbound Emerg Dis; 2014 Jun; 61(3):277-84. PubMed ID: 23164336
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Quantitative characteristics of the foot-and-mouth disease carrier state under natural conditions in India.
    Hayer SS; Ranjan R; Biswal JK; Subramaniam S; Mohapatra JK; Sharma GK; Rout M; Dash BB; Das B; Prusty BR; Sharma AK; Stenfeldt C; Perez A; Rodriguez LL; Pattnaik B; VanderWaal K; Arzt J
    Transbound Emerg Dis; 2018 Feb; 65(1):253-260. PubMed ID: 28251837
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of the solid phase competition ELISA for detecting antibodies against the six foot-and-mouth disease virus non-O serotypes.
    Li Y; Swabey KG; Gibson D; Keel PJ; Hamblin P; Wilsden G; Corteyn M; Ferris NP
    J Virol Methods; 2012 Aug; 183(2):125-31. PubMed ID: 22561986
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluating the efficacy of hydrogen peroxide vapour against foot-and-mouth disease virus within a BSL4 biosafety facility.
    Petit BM; Almeida FC; Uchiyama TR; Lopes FOC; Tino KH; Chewins J
    Lett Appl Microbiol; 2017 Oct; 65(4):281-284. PubMed ID: 28736948
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The history of research in foot-and-mouth disease.
    Brown F
    Virus Res; 2003 Jan; 91(1):3-7. PubMed ID: 12527434
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies I: Benefits of Higher Potency Vaccines and Associated NSP DIVA Test Systems in Post-Outbreak Surveillance.
    Barnett PV; Geale DW; Clarke G; Davis J; Kasari TR
    Transbound Emerg Dis; 2015 Aug; 62(4):367-87. PubMed ID: 24112127
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A survey on the frequency of foot-and-mouth disease virus carriers in cattle in north-east of Iran by RT-PCR: implications for revising disease control strategy.
    Rashtibaf M; Sharifi K; Zibaee S; Dehghani H
    Transbound Emerg Dis; 2012 Dec; 59(6):482-9. PubMed ID: 22222047
    [TBL] [Abstract][Full Text] [Related]  

  • 76. History and epidemiology of foot-and-mouth disease in Zambia: a review.
    Perry BD; Hedger RS
    Trop Anim Health Prod; 1984 May; 16(2):107-14. PubMed ID: 6091305
    [No Abstract]   [Full Text] [Related]  

  • 77. [Experience in the use of semiautomatic syringes for vaccination of livestock against foot-and-mouth disease].
    Titov VV; Akhmetzianov FKh; Kazakov VV
    Veterinariia; 1968 Sep; 45(9):32. PubMed ID: 5754218
    [No Abstract]   [Full Text] [Related]  

  • 78. [A review of the risks involved in the import of foot and mouth disease vaccinated animals and the products of such animals].
    Sutmoller P
    Tijdschr Diergeneeskd; 2004 Jun; 129(12):408-9. PubMed ID: 15232965
    [No Abstract]   [Full Text] [Related]  

  • 79. An epidemiological analysis of the foot-and-mouth disease epidemic in Miyazaki, Japan, 2010.
    Nishiura H; Omori R
    Transbound Emerg Dis; 2010 Dec; 57(6):396-403. PubMed ID: 20723164
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Some costs of animal disease outbreaks cannot be counted.
    Nolen RS
    J Am Vet Med Assoc; 2002 Nov; 221(9):1235-6. PubMed ID: 12418683
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.